天津医药 ›› 2026, Vol. 54 ›› Issue (11): 1204-1208.doi: 10.11958/20260132

• 临床研究 • 上一篇    下一篇

突发性耳聋患者血清miR-204-5p、Bcl-2水平与病情严重程度及预后的关系

金稳1(), 焦婵2, 王园园1, 曹成1, 朱俊1,△()   

  1. 1 十堰市太和医院耳鼻咽喉头颈外科 (邮编 442000)
    2 十堰市茅箭区人民医院儿科
  • 收稿日期:2026-01-08 修回日期:2026-04-01 出版日期:2026-11-15 发布日期:2026-11-10
  • 通讯作者: 朱俊 E-mail:15997818769@163.com;1134367992@qq.com
  • 作者简介:金稳(1993),男,医师,主要从事耳科学方面研究。E-mail:15997818769@163.com

The relationship between serum miR-204-5p and Bcl-2 with severity and prognosis in patients with sudden sensorineural hearing loss

JIN Wen1(), JIAO Chan2, WANG Yuanyuan1, CAO Cheng1, ZHU Jun1,△()   

  1. 1 Department of Otolaryngology-Head and Neck Surgery, Taihe Hospital, Shiyan 442000, China
    2 Department of Pediatrics, People's Hospital of Maojian District, Shiyan City
  • Received:2026-01-08 Revised:2026-04-01 Published:2026-11-15 Online:2026-11-10
  • Contact: ZHU Jun E-mail:15997818769@163.com;1134367992@qq.com

摘要:

目的 探究突发性耳聋(SSNHL)患者血清微小RNA(miR)-204-5p、B细胞淋巴瘤-2(Bcl-2)表达水平与病情严重程度及预后的关系。方法 选取2021年1月—2024年1月在本院就诊的SSNHL患者90例作为研究对象;根据听力损失情况将SSNHL患者按照纯音平均听阈(PTA)分为轻度组、中度组、重度组和极重度组;根据疾病转归情况将其分为预后不良组和预后良好组。采用荧光定量PCR测定血清miR-204-5p水平;采用酶联免疫吸附(ELISA)法测定血清Bcl-2水平;Pearson相关分析血清miR-204-5p与Bcl-2水平的相关性;Logistic回归分析SSNHL患者预后不良的影响因素。受试者工作特征(ROC)曲线分析血清miR-204-5p、Bcl-2水平预测SSNHL患者预后不良的效能。结果 轻度组SSNHL患者miR-204-5p水平最低,miR-204-5p水平随病情加重而升高(P<0.05),轻度组SSNHL患者血清Bcl-2水平最高,Bcl-2水平随病情加重而降低(P<0.05);预后良好组患者血清miR-204-5p水平显著低于预后不良组,Bcl-2水平显著高于预后不良组(P<0.05);SSNHL患者血清miR-204-5p与Bcl-2水平呈负相关(r=-0.505,P<0.01);高水平的miR-204-5p是SSNHL患者预后不良的独立危险因素,高水平的Bcl-2是SSNHL患者预后不良的独立保护因素(P<0.05);血清miR-204-5p、Bcl-2水平及其联合预测SSNHL患者预后不良的曲线下面积(AUC)分别为0.759(95%CI:0.655~0.864)、0.770(95%CI:0.670~0.869)、0.900(95%CI:0.828~0.972),联合预测效果优于单独预测(ZmiR-204-5p-联合预测=2.175、ZBcl-2-联合预测=2.081,均P<0.05)。结论 SSNHL患者血清miR-204-5p、Bcl-2水平变化可有效预测患者预后。

关键词: 聋, 微RNAs, 原癌基因蛋白质c-bcl-2, 预后, 突发性耳聋, 微小RNA-204-5p

Abstract:

Objective To investigate the relationship between serum microRNA (miR)-204-5p and B-cell lymphoma 2 (Bcl-2) in patients with sudden sensorineural hearing loss (SSNHL) and the severity and prognosis of the disease. Methods A total of 90 SSNHL patients who visited our hospital from January 2021 to January 2024 were identified as the study subjects. SSNHL patients were assigned into the mild group, the moderate group, the severe group and the extremely severe group based on their hearing loss evaluated by average pure tone hearing threshold. Complying with the outcome of the disease, patients were assigned into the poor prognosis group and the good prognosis group. The serum miR-204-5p was measured using fluorescence quantitative PCR. The serum Bcl-2 was measured using enzyme-linked immunosorbent assay(ELISA) method. Pearson method was used to analyze the correlation between serum miR-204-5p and Bcl-2. Logistic regression was used to analyze the factors associated with poor prognosis in SSNHL patients. ROC curve was used to analyze the efficacy of serum miR-204-5p and Bcl-2 in predicting poor prognosis in SSNHL patients. Results The miR-204-5p was the lowest in the mild group, and the miR-204-5p increased with the aggravation of the disease (P<0.05). The serum Bcl-2 was the highest in the mild group, and the Bcl-2 level decreased with the aggravation of the disease (P<0.05). The serum miR-204-5p level was lower in the good prognosis group than that of the poor prognosis group (P<0.05). The serum Bcl-2 level was higher in the good prognosis group than that of the poor prognosis group (P<0.05). The serum miR-204-5p level was negatively correlated with the serum Bcl-2 level (r=-0.505, P<0.01). The higher miR-204-5p was the independent risk factor for poor prognosis of SSNHL patients (P<0.05), and high Bcl-2 was the independent protective factor for poor prognosis in SSNHL patients (P<0.05). The area under the curve (AUC) of serum miR-204-5p, Bcl-2 and their combined prediction of poor prognosis in SSNHL patients was 0.759(95%CI:0.655-0.864), 0.770(95%CI:0.670-0.869) and 0.900(95%CI:0.828-0.972), respectively. The effect of combined prediction was superior to that of individual prediction (ZmiR-204-5p - combined prediction=2.175, ZBcl-2 - combined prediction=2.081, both P<0.05). Conclusion The changes of serum miR-204-5p and Bcl-2 levels in SSNHL patients can effectively predict the prognosis of SSNHL patients.

Key words: deafness, microRNAs, proto-oncogene proteins c-bcl-2, prognosis, sudden sensorineural hearing loss, microRNA-204-5p

中图分类号: